<p>This activity was supported by an educational grant from Bristol Myers Squibb. Please go to <a href="http://academiccme.com/EPCNCFBE">⁠</a> <a href="academiccme.com/⁠ccrwestsle⁠" target="_blank" rel="noopener noreferer">academiccme.com/ccrwestsle</a>⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.</p>

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠ academiccme.com/ccrwestsle⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

<p>This activity was supported by an educational grant from Bristol Myers Squibb. Please go to&nbsp;<a href="http://academiccme.com/EPCNCFBE" rel="noopener noreferrer">⁠</a>&nbsp;<a href="academiccme.com/⁠ccrwestsle⁠" rel="noopener noreferrer">academiccme.com/ccrwestsle</a>⁠&nbsp;and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.</p>

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice

Share Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Sign up to save your podcasts

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

More shows like AcademicCME Podcast

The Medbullets Step 1 Podcast